Multisystem Inflammatory Syndrome in Children: Clinical Trials

1 trial for Multisystem Inflammatory Syndrome in Children, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Multisystem Inflammatory Syndrome in Children: new trials by email Literature Review of Multisystem Inflammatory Syndrome in Children trials Research Report on Multisystem Inflammatory Syndrome in Children

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AT1001 for the Treatment of COVID-19 Related MIS-C
Larazotide Acetate, Placebo - Covid19, Multisystem Inflammatory Syndrome in Children
Phase 2TerminatedMassachusetts General Hospital122021-10-012024-06-13

Narrower conditions

COVID-19 (1)  ·  pediatric multisystem inflammatory disease, COVID-19 related (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Interventions

larazotide acetate (1)

Sponsors

Massachusetts General Hospital (1)

Countries

United States (1)

Results publications

PMID 40737433